Q2 2010

Filed Aug 17, 2010 · 10-Q · 48 days after period end · 0001144204-10-045173

Q2 2010 · 10-Q

Revenue

$0.00

no prior Q2 2009 on file

Net Income

-$8.73M

no prior Q2 2009 on file

EPS Diluted

-$0.14

no prior Q2 2009 on file

Operating Income-$3,106,000—

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 17, 2010 · 48 d after period end

Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR